Donor Bone Marrow Offered to Patients With Blood Cancers or Blood Disorders
Offers donor bone marrow transplant to people with blood cancers or disorders.
Plain-language title generated from the registry record
Registry title: HPC Offered for PRESERVE Expansion
Key facts
- Where
- Birmingham, Columbus, Detroit, Duarte, and Nashville, United StatesSee the 5 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 80 years old?
Source: NCT07145411, who can take part
Where in United States
- University of Alabama BirminghamBirmingham, United StatesTaking people
- The Ohio State University Medical CenterColumbus, United StatesTaking people
- Henry Ford HealthDetroit, United StatesTaking people
- City of HopeDuarte, United StatesTaking people
- TriStar Centennial Medical centerNashville, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ossium Health, Inc.
- Trial code
- NCT07145411
- Record updated
- 6 November 2026
- Original description
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow productRead full original descriptionShow less
A Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for HOPE Patients With Hematologic Malignancies or Disorders
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
Inclusion: Patients aged 12-80 may be eligible* to receive bone marrow for transplantation through the Ossium HOPE Program if:; Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks.